Variable | X2 | HR | 95% CI | p |
---|---|---|---|---|
NYHA class | 7.5 | 1.75 | 1.15 to 2.68 | 0.001 |
Karnofsky Index | 21.3 | 0.91 | 0.88 to 0.95 | 0.0001 |
CMR parameters | ||||
AAPSE (mm) | 15.6 | 0.10 | 0.03 to 0.34 | 0.0002 |
MAPSE anterior (mm) | 8.1 | 0.19 | 0.06 to 0.60 | 0.004 |
MAPSE anterolateral (mm) | 11.7 | 0.23 | 0.10 to 0.56 | 0.001 |
MAPSE inferolateral (mm) | 6.2 | 0.36 | 0.16 to 0.83 | 0.02 |
MAPSE inferior (mm) | 9.0 | 0.26 | 0.10 to 0.63 | 0.003 |
MAPSE inferoseptal (mm) | 7.7 | 0.26 | 0.10 to 0.68 | 0.01 |
TAPSE (mm) | 6.7 | 0.94 | 0.90 to 0.99 | 0.01 |
GLS (%) | 11.7 | 1.12 | 1.05 to 1.19 | 0.0006 |
LSbasal (%) | 8.3 | 1.08 | 1.02 to 1.13 | 0.006 |
LSmid (%) | 12.8 | 1.13 | 1.06 to 1.21 | 0.0005 |
LSapical (%) | 6.9 | 1.07 | 1.02 to 1.12 | 0.005 |
Ejection Fraction (%) | 11.6 | 0.95 | 0.93 to 0.98 | 0.0007 |
Septal wall (mm) | 0.7 | 1.03 | 0.96 to 1.11 | n.s. |
Relative LV Mass (g/m2) | 1.8 | 1.01 | 0.99 to 1.02 | n.s. |
LA dilation a | 0.02 | 1.05 | 0.55 to 1.97 | n.s. |
Relative LGE (%) | 4.4 | 1.02 | 1.00 to 1.04 | 0.03 |
Qualitative LGE (n) | 6.8 | 1.50 | 1.09 to 2.06 | 0.009 |
Laboratory data | ||||
cTNT ULN a | 5.3 | 1.94 | 1.09 to 3.45 | 0.02 |
log NT-proBNP (pg/mL) | 13.0 | 1.52 | 1.20 to 1.94 | 0.0006 |
MDRD (mL/min/1.73m2) | 0.2 | 1.00 | 0.99 to 1.01 | n.s. |
log FLC difference (mg/dL) | 6.3 | 1.71 | 1.10 to 2.65 | 0.02 |